Share your thoughts on the future of asthma treatment. Take two short surveys below by Jan. 12, 2020, 11:59 p.m. ET, and we'll submit your responses to be considered for updates to the Guidelines for the Diagnosis and Management of Asthma.
The surveys below will only take a few minutes to complete. Share your thoughts on:
- Using your long-term control inhaler as your quick-relief inhaler
- How you reduce allergens to prevent asthma symptoms, especially dust mites
The Asthma and Allergy Foundation of America (AAFA) will send your comments to the National Heart, Lung, and Blood Institute (NHLBI) to review as they finalize the new guidelines. We want your voice to be heard.
What Are the Guidelines for the Diagnosis and Management of Asthma?
Doctors in the United States use the Guidelines for the Diagnosis and Management of Asthma, also known as the Expert Panel Report-3 (EPR-3), to diagnose and manage asthma.
This report is written by doctors and educators who are experts in asthma care. It is published by the NHLBI. It serves as the gold standard of clinical care for people with asthma. The report includes guidance on how to diagnose asthma, medicine therapy, the importance of Asthma Action Plans, how to reduce triggers and much more.
EPR-3 was released in 2007. There has not been an update to the guidelines until now. The NHLBI has just released the draft of EPR-4. They are currently accepting public comments.
Take the short surveys below by Jan. 12, 2020, 11:59 p.m. ET. We will submit all of your responses with AAFA’s response.